Summary
This 8-K filing from Gilead Sciences, Inc. (GILD) on August 5, 2008, primarily announces the appointment of Richard J. Whitley, MD, to its Board of Directors, effective July 30, 2008. Dr. Whitley, who previously served on the company's Scientific Advisory Board since 2003, will also continue his role on the Scientific Committee of the Board. His appointment is expected to strengthen the company's scientific expertise at the directorial level. The filing also details Dr. Whitley's compensation for his new role, which includes stock options and a prorated annual cash retainer. This appointment signals Gilead's ongoing commitment to leveraging scientific talent and advisory input to guide its strategic direction, particularly in its research and development efforts.
Key Highlights
- 1Richard J. Whitley, MD, appointed to the Board of Directors, effective July 30, 2008.
- 2Dr. Whitley will serve on the Board's Scientific Committee.
- 3Dr. Whitley previously served on Gilead's Scientific Advisory Board from 2003 to July 30, 2008.
- 4Dr. Whitley will continue to serve on the Scientific Advisory Board but will no longer be compensated for that role.
- 5Compensation for Dr. Whitley's director role includes a grant of 30,000 stock options.
- 6Dr. Whitley will receive a prorated annual cash retainer of $55,232.88.
- 7A press release announcing Dr. Whitley's election is attached as Exhibit 99.1.